2023-08-07 17:35:58 ET
- Halozyme Therapeutics ( NASDAQ: HALO ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, after market close.
- The consensus EPS Estimate is $0.64 (+20.8% Y/Y) and the consensus Revenue Estimate is $199.95M (+31.2% Y/Y).
- Over the last 2 years, HALO has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward. Revenue estimates have seen 2 upward revisions and 2 downward.
For further details see:
Halozyme Therapeutics Q2 2023 Earnings Preview